HealthQuill thalassaemia
British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a standard-of-care combination, according to the company.
Drugs Health

India grapples with thalassaemia crisis with 42 million carriers

HQ Team May 8, 2025: As the world observes World Thalassaemia Day on May 8, India faces a harsh reality—it is often called.

Read More